Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Cortical Dopamine Transmission as Measured with the [11C]FLB 457 - Amphetamine PET Imaging Paradigm Is Not Influenced by COMT Genotype.

Narendran R, Tumuluru D, May MA, Chowdari KV, Himes ML, Fasenmyer K, Frankle WG, Nimgaonkar VL.

PLoS One. 2016 Jun 20;11(6):e0157867. doi: 10.1371/journal.pone.0157867.

2.

Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A.

Biol Psychiatry. 2017 Jan 1;81(1):31-42. doi: 10.1016/j.biopsych.2016.03.2104. Review.

PMID:
27206569
3.

Application of cross-species PET imaging to assess neurotransmitter release in brain.

Finnema SJ, Scheinin M, Shahid M, Lehto J, Borroni E, Bang-Andersen B, Sallinen J, Wong E, Farde L, Halldin C, Grimwood S.

Psychopharmacology (Berl). 2015 Nov;232(21-22):4129-57. doi: 10.1007/s00213-015-3938-6. Review.

4.

Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.

Alakurtti K, Johansson JJ, Joutsa J, Laine M, Bäckman L, Nyberg L, Rinne JO.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1199-205. doi: 10.1038/jcbfm.2015.53.

5.

Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.

Wing VC, Payer DE, Houle S, George TP, Boileau I.

Neuropsychopharmacology. 2015 May;40(6):1417-27. doi: 10.1038/npp.2014.327.

6.

Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development.

Le Foll B, Wilson AA, Graff A, Boileau I, Di Ciano P.

Front Pharmacol. 2014 Jul 10;5:161. doi: 10.3389/fphar.2014.00161. Review.

7.

Decreased prefrontal cortical dopamine transmission in alcoholism.

Narendran R, Mason NS, Paris J, Himes ML, Douaihy AB, Frankle WG.

Am J Psychiatry. 2014 Aug;171(8):881-8. doi: 10.1176/appi.ajp.2014.13121581.

8.

In vivo imaging of cerebral dopamine D3 receptors in alcoholism.

Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN, Beaver JD, Waldman A, Nutt DJ, Bani M, Merlo-Pich E, Rabiner EA, Lingford-Hughes A.

Neuropsychopharmacology. 2014 Jun;39(7):1703-12. doi: 10.1038/npp.2014.18.

9.

[18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.

Rami-Mark C, Zhang MR, Mitterhauser M, Lanzenberger R, Hacker M, Wadsak W.

Nucl Med Biol. 2013 Nov;40(8):1049-54. doi: 10.1016/j.nucmedbio.2013.08.007.

10.

Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors.

Narendran R, Himes M, Mason NS.

PLoS One. 2013 Sep 30;8(9):e76905. doi: 10.1371/journal.pone.0076905.

11.

Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study.

Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J, Chen CM, Deuitch L, Frankle WG, Bradberry CW.

Mol Psychiatry. 2014 Mar;19(3):302-10. doi: 10.1038/mp.2013.9. Erratum in: Mol Psychiatry. 2014 Mar;19(3):399.

12.

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.

Forsberg A, Juréus A, Cselényi Z, Eriksdotter M, Freund-Levi Y, Jeppsson F, Swahn BM, Sandell J, Julin P, Schou M, Andersson J, Johnström P, Varnäs K, Halldin C, Farde L, Svensson S.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):580-93. doi: 10.1007/s00259-012-2322-6.

13.

Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder.

Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N.

Transl Psychiatry. 2012 May 22;2:e120. doi: 10.1038/tp.2012.40.

14.

Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.

Eisenstein SA, Koller JM, Piccirillo M, Kim A, Antenor-Dorsey JA, Videen TO, Snyder AZ, Karimi M, Moerlein SM, Black KJ, Perlmutter JS, Hershey T.

Synapse. 2012 Sep;66(9):770-80. doi: 10.1002/syn.21566.

15.

Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457.

Ishibashi K, Ishii K, Oda K, Mizusawa H, Ishiwata K.

PLoS One. 2011 Mar 9;6(3):e17723. doi: 10.1371/journal.pone.0017723.

16.

Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.

Narendran R, Mason NS, Chen CM, Himes M, Keating P, May MA, Rabiner EA, Laruelle M, Mathis CA, Frankle WG.

Synapse. 2011 Oct;65(10):991-7. doi: 10.1002/syn.20926.

18.

Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.

Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A.

Biol Psychiatry. 2010 Oct 1;68(7):634-41. doi: 10.1016/j.biopsych.2010.05.027.

19.

Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.

Narendran R, Mason NS, May MA, Chen CM, Kendro S, Ridler K, Rabiner EA, Laruelle M, Mathis CA, Frankle WG.

Synapse. 2011 Jan;65(1):35-40. doi: 10.1002/syn.20813.

20.

High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT.

J Cereb Blood Flow Metab. 2010 May;30(5):994-1007. doi: 10.1038/jcbfm.2009.270.

Items per page

Supplemental Content

Support Center